Friday, December 12, 2014 3:35:02 PM
Dear Stockholders,
It was brought to our attention that there have been questions raised today on the internet regarding the recent dismissal of a legal action regarding our technology. Fueltek , Inc. an affiliated company of CyberFuels sought a temporary injunction against the defendants, Mathew Zuckerman, Fueltec,Inc. and Z Fuels, Inc. from conducting business using the above mentioned technology. On November 22 , 2013 the Palm Beach Circuit Court granted Fueltek’s motion and then issued the temporary injunction. On Dec.8, 2014, Fueltek,Inc., filed a voluntary dismissal of its action without prejudice. This fact notwithstanding, should anyone interfere or attempt to interfere with Fueltek’s or CyberFuels’ intellectual property rights, CyberFuels will take all necessary steps to protect itself, including but not limited to seeking an additional injunction or any other legal remedy that might be deemed necessary.
The fact that these baseless reports were posted on the internet and had an adverse effect on Encountercare’s Stock is indeed unfortunate. I want to assure our stockholders that our company is in fact pursuing the sale of our product line EcoFlex 96, Dynamo Cetane Booster and Dynamo Octane Booster. As reported earlier in my last update, we expect to begin selling our fuel in Florida in the near future. The State has given us guidance in a letter on the steps necessary to begin selling the fuel and we believe that we meet all the criteria that it has given to us.
Additionally, while we have not finalized contracts on our dynamo products, we are still in multiple contract negotiations with national and international distributors for the products and while we cannot with certainty state that we will be successful in signing these contracts, we can say that we are hopeful and expect that we will sign some of them.
Lastly, we want to thank you for your confidence. We trust and believe that good things are ahead for our company and its stockholders. We will provide further updates and progress on the sales of our products as they become available.
Regards,
Ron Mills
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM